The Ca 21 ion is an intracellular messenger essential for neuronal survival and function. The excitatory neurotransmitter, glutamate is released and accumulated in the synaptic cleft under pathological conditions such as hypoxic ischemia or trauma, which result in in¯ux and accumulation of Ca 21 through Ca
21
-permeable ionotropic glutamate receptors sensitive to NMDA and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate (Choi and Rothman 1990; McIntosh et al. 1996) . Accumulated Ca 21 can trigger the production of various toxic substances such as NO through the activation of nitric oxide synthase, reactive oxygen species (ROS), and arachidonic acid (Lazarewicz et al. 1990; Dykens 1994; Dawson and Dawson 1996) . Although internucleosomal DNA fragmentation and chromatin condensation have been considered as evidence for apoptosis occurring in the process of glutamate neurotoxicity or excitotoxicity (Ankarcrona et al. 1995) , pharmacological and ultrastructural analysis supports necrosis as a predominant pattern of excitotoxicity that is accompanied by marked swelling of cytoplasmic organelles due to Na 1 overload (Choi 1987; Gwag et al. 1997) . Interestingly, lowering extracellular concentration of Na 1 unveils neuronal apoptosis following exposure to NMDA (Yu et al. 1999) , suggesting that preferential entry of Ca 21 cause apoptosis. In support of this, administration of selective Ca 21 carriers induces apoptosis of neuronal and non-neuronal cells (Wyllie et al. 1984; Gwag et al. 1999) .
Mediators downstream from Ca 21 -induced apoptosis have been identi®ed. Ca 21 ionophores or glutamate induce activation of calcineurin, a Ca 21 -dependent serine±threonine phosphatase, that dephosphorylates Bcl-XL/Bcl-2-associated death promoter (BAD) . Dephosphorylated BAD is translocated into the mitochondria and heterodimerized with antiapoptotic proteins such as Bcl-2 and Bcl-x L , which results in opening of the mitochondrial permeability transition pore and cytochrome c release (Jacotot et al. 1999; Wang et al. 1999) . Released cytochrome c binds to apoptotic protease-activating factor-1 (Apaf-1), inducing recruitment and activation of procaspase-9 that stimulates caspase-3 and other downstream caspases for execution of apoptosis (Zou et al. 1997 (Zou et al. , 1999 Pan et al. 1998) . In addition to caspases, the Ca 21 -activated cysteine proteases calpains appear to mediate apoptosis in thymocytes and neurons (Squier et al. 1994; Jordan et al. 1997) .
In addition to Ca 21 overload, reducing levels of intracellular or extracellular Ca 21 can cause apoptotic cell death evident by internucleosomal DNA fragmentation, aggregation and condensation of nuclear chromatin, and early collapse of nuclear membrane (Kluck et al. 1994) . Systemic administration of NMDA glutamate receptor antagonists produces neuronal vacuolization and death in several brain areas (Olney et al. 1989) . The TUNEL method and electron microscope analysis demonstrate that NMDA antagonists cause neuronal apoptosis (Hwang et al. 1999; Ikonomidou et al. 1999) . Cortical neurons treated with high doses of voltage-gated Ca 21 channel antagonists undergo apoptosis accompanied by cell body shrinkage and prevented by inhibitors of protein synthesis (Koh and Cotman 1992) . Thus, it is conceivable that neurons can undergo apoptotic degeneration when [Ca 21 ] i is abnormally reduced. However, signaling pathways underlying Ca 21 de®ciency-induced neurotoxicity remain to be delineated. In the present study, we have examined occurrence of apoptosis or necrosis in Ca 21 de®ciency-induced neurotoxicity, turning to the selective Ca 21 chelator BAPTA-AM, and putative roles of the mitochondrial death mediators and reactive oxygen species in the process of Ca 21 de®ciency-induced neurotoxicity. NMDA, , and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) were obtained from RBI (Natick, MA, USA); cycloheximide were purchased from Sigma (St Louis, MO, USA); Trolox was obtained from Aldrich (Milwaukee, WI, USA); Z-VAD-fmk and Z-DEVDfmk were obtained from Enzyme System Products (Livermore, CA, USA); 6-carboxy-2,7-dichlorodihydro¯uorescein diacetate, di(acetoxymethylester) (DCDHF), dihydrorhodamine 123 and hydroethidium were purchased from Molecular Probes (Eugene, OR, USA); Trypan blue stain 0.4% was purchased from GIBCO± BRL (Grand island, NY, USA).
Materials and methods

Materials
Primary mouse cortical cell cultures
Mouse cortical cell cultures were prepared as previously described (Noh and Gwag 1997) . Animals were handled in accordance with a protocol approved by our institutional animal care committee. Cerebral cortices were removed from brains of the 14-day-old fetal mice, gently triturated with a large-bore Pasteur pipette 3±4 times, dissociated into individual cells using a small-bore Pasteur pipette, and plated on 6-or 24-well plates (®ve hemispheres/plate, approximately 2.5 Â 10 5 cells/plate) precoated with 100 mg/mL poly-d-lysine and 4 mg/mL laminine. Plating media consisted of Eagle's minimal essential media (MEM, Earle's salts, supplied glutamine-free) supplemented with 5% horse serum, 5% fetal bovine serum, 2 mm glutamine, and 21 mm glucose. Cultures were maintained at 378C in a humidi®ed 5% CO 2 atmosphere. Cytosine arabinofuranoside (®nal concentration, 10 mm) was added to cultures at 7±9 days in vitro (DIV 7±9) where glia became con¯uent underneath neurons. Two days later, cultures were shifted into a growth medium identical to the plating medium but lacking fetal serum. All experiments were performed at DIV 10±12.
Assessment of neuronal injury
The cultures were then stained with 0.4% Trypan blue and percentage of neuronal death was assessed by counting viable neurons, mean^SEM (n 16±24 ®eld randomly chosen from four wells per condition), and comparing with sham wash controls ( 0%).
Glial cell culture
Neocortices were prepared from postnatal ICR mice (P1±3) and mechanically triturated. Dissociated cells were plated on 24-well plates (0.5 hemispheres/plate) in a plating medium consisting of Eagle's minimal essential media (MEM, Earle's salts, 11090±081) supplemented with 5% horse serum, 5% fetal bovine serum, 2 mm glutamine and 21 mm glucose. Cultures were maintained at 378C in a humidi®ed 5% CO 2 atmosphere for 2 to 6 weeks.
Assessment of glial cell death
Overall cell injury was assessed microscopically under phasecontrast optics or by measuring amount of lactate dehydrogenase (LDH) released into the bathing medium 24 h after neurotoxic insults. The percent neuronal death was normalized to the mean LDH value released 24 h after continuous exposure to 0.2% triton x-100 ( 100) or a sham control ( 0).
Transmission electron microscopic study
Cultures were ®xed in Karnovsky's ®xative solution (1% paraformaldehyde, 2% glutaraldehyde, 2 mm calcium chloride, 100 mm cacodylate buffer, pH 7.4) for 2 h, washed with cacodylate buffer, and post-®xed in 1% osmium tetroxide and 1.5% potassium ferrocyanide for 1 h. Cells were then stained en bloc in 0.5% uranyl acetate, dehydrated through a graded ethanol series and embedded in Poly/Bed 812 resin (Pelco, CA, USA). Cells were sectioned using Reichert Jung Ultracut S (Leica, Cambridge, UK). After staining cells with uranyl acetate and lead citrate, cells were observed and photographed under Zeiss EM 902 A.
ROS imaging
Levels of intracellular ROS were analyzed as previously described . In brief, cortical cell cultures (DIV 10±12) grown on a glass-bottom dish were loaded with a ROS-detectinḡ uorescence dye [10 mm dichlorodihydro¯uorescein diacetate (DCDHF-DA) for overall levels of intracellular ROS, 5 mm dihydrorhodamine 123 for mitochondrial ROS, or 5 mm hydroethidium for superoxide; Molecular Probes, Eugene, OR] plus 2% Pluronic F-127 in HEPES-buffered control salt solution (HCSS) containing 120 mm NaCl, 5 mm KCl, 1.6 mm MgCl 2 , 2.3 mm CaCl 2 , 15 mm Glucose, 20 mm HEPES, and 10 mm NaOH. Cultures were incubated for 20 min at 378C, washed three times with HCSS, and the¯uorescence signal of dichloro¯uorescein diacetate (E x 490 nm, E m 510 nm), rhodamine 123 (E x 490 nm, E m 510 nm), and ethidium (E x 546, E m 590) were analyzed on the stage of a Nikon Diaphot (Nikon, Tokyo, Japan) inverted microscope equipped with a 100-W Xenon lamp. Intracellular levels of ROS were analyzed within 3 s after illumination using a Quanticell 700 system (Applied Imaging, Newcastle, UK).
Subcelluar fractionation
Cells were resuspended in an isotonic buffer containing 10 mm HEPES pH 8.0, 250 mm sucrose, 1 mm EDTA, 1 mm EGTA, 1 mm dithiothreitol (DTT), 2 mm phenylmethylsulfonyl¯uoride (PMSF), 100 mg/mL leupeptin, 10 mg/mL pepstatin A, and homogenized using a 26 G syringe needle. Homogenates were centrifuged at 600 g for 10 min to remove nuclei and unbroken cells. The supernatant was centrifuged at 15 000 g for 20 min to precipitate the heavy membrane fraction. The soluble fraction was subjected to western blot in order to analyze cytoplasmic levels of Bax.
Western blot analysis
Cells were lysed in a lysis buffer containing 50 mm Tris-HCl pH 7.5, 150 mm NaCl, 1% Nonidet P40, 0.5% deoxycholic acid, 0.1% sodium dodecyl sulfate (SDS), 1 mm PMSF, and 100 mg/mL leupeptin. Cell lysates were centrifuged at 13 000 g for 10 min, the supernatants collected, subjected to electrophoresis on a 10% SDS±polyacrylamide gel, and transferred to a nitrocellulose membrane. The blot was incubated in 5% non-fat dry milk for 30 min, reacted with primary antibodies overnight at 48C, and then incubated with a biotinylated anti-mouse or rabbit secondary antibody for 4 h. Signals were detected using the VECTASTAIN ABC kit (Vector Lab., Burlingame, CA, USA) and luminol as an enhanced chemiluminescence substrate (Amersham, Buckinghamshire, UK), and then analyzed using Kodak X-Omat ®lm or an image analyser LAS1000 (Fuji Photo Film Co., Ltd). The PHF-1 tau monoclonal antibody recognizes tau phosphorylated at Ser396 and Ser404 (a generous gift from Dr P. Davis, Department of Pathology, Albert Einstein College of Medicine, Bronx, NY, USA).
The rabbit polyclonal antibody for caspase-3 recognizes active caspase 3 of 17±20 kDa (New England Biolabs, Beverly, MA, USA). The cytochrome c monoclonal and Bax polyclonal antibodies were obtained from Pharmingen (San Diego, CA, USA).
Immunocytochemistry
Cortical cell cultures (DIV 10±12) grown on a glass-bottom dish were washed three times with phosphate-buffered saline, ®xed with 4% paraformaldehyde, and incubated with 5% goat serum containing 0.3% Triton X-100 for 30 min. Cultures were then reacted with anti-cytochrome c or Bax antibody (1 : 100 dilution) overnight at 48C. Cultures were incubated in a FITC-conjugated secondary antibody solution (1 : 150 dilution) for 2±4 h and then examined using confocal microscope (Bio-Rad, UK).
Results
Temporal patterns of BAPTA-AM neurotoxicity: early apoptosis and delayed necrosis Mixed cortical cell cultures of neurons and glia exposed to 20 mm BAPTA-AM resulted in widespread neuronal death in the absence of glial damage (Fig. 1 ). Approximately 40% neurons died at 12 h after exposure to BAPTA-AM and were accompanied by shrinkage of cell body, early collapse of nuclear membrane, and aggregation and condensation of nuclear chromatin characteristic of apoptosis (Figs 1b and g and Fig. 2c ). The apoptotic neurons showed intact plasma membrane and remained without lysis over 24 h following exposure to BAPTA-AM (Figs 1i and 2c) . Although the number of apoptotic neurons was not increased 24 h later, neurons underwent further degeneration (approximately 80%) over the next 24 h following exposure to BAPTA-AM (Figs 1i and 2c ). This delayed neuronal death was marked by swelling of cell body and mitochondria, collapse of plasma membrane prior to nuclear membrane, and scattering condensation of nuclear chromatin (Figs 1c and h), suggesting that cortical neurons exposed to BAPTA-AM undergo biphasic degeneration: early apoptosis and late necrosis. This degeneration pattern seemed to be speci®c to Ca 21 de®ciency as cortical neurons exposed to butoxycarbonylaspartate-¯uoromethylketone -N,N,N H ,N H -tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN), a selective zinc chelator, for 12±24 h died without swelling of cell body (Figs 1d and  e) . Analysis of neuronal death under transmission electron microscopy demonstrated that treatment with BAPTA-AM injured cortical neurons primarily through apoptosis within 12 h and caused additional neuronal death by necrosis over 24 h (Fig. 2i) .
Cycloheximide prevents both apoptosis and necrosis following exposure to BAPTA-AM Cycloheximide, a protein synthesis inhibitor, was shown to block apoptosis of postmitotic neurons. Consistent with this, inclusion of cycloheximide prevented apoptotic neuronal death occurring within 12 h following exposure to BAPTA-AM (Fig. 2) . Interestingly, cycloheximide also blocked swelling and lysis of neuronal cell body appearing 12±24 h after exposure to BAPTA-AM.
Caspase inhibitors and trolox attenuate BAPTA-AMinduced apoptosis and necrosis, respectively We performed pharmacological experiments to determine if excitotoxicity, free radicals, or caspases would contribute to BAPTA-AM neurotoxicity. Inclusion of zVAD-fmk, a broad spectrum caspase inhibitor, or DEVD-amc, a selective inhibitor of caspase-3, prevented BAPTA-AM-induced neuronal apoptosis (Figs 3a and e) . However, this protective effect of caspase inhibitors disappeared within 24 h and most neurons continued to die (Fig. 3e) . Degenerating neurons revealed cell body swelling in the presence of caspase inhibitors, suggesting that inhibiting caspases converted apoptosis to necrosis (Figs 3b and e) . While trolox, a membrane-permeable form of vitamin E, did not attenuate the apoptosis component of BAPTA-AM neurotoxicity (Figs 3c and e) , it completely prevented slowly appearing necrosis of cortical neurons over the next 24 h (Figs 3d and  e) . Inclusion of MK-801 plus CNQX, selective antagonists of NMDA and AMPA/kainate receptors, did not prevent BAPTA-AM neurotoxicity. Thus, treatment with BAPTA-AM likely causes caspase-3-mediated apoptosis and ROSmediated necrosis, respectively.
BAPTA-AM-induced apoptosis: activation of the Bax-cytochrome c-caspase-3 death pathway The pro-apoptotic protein Bax is required for neuronal apoptosis that is induced by trophic factor deprivation (i) Neuronal apoptosis or necrosis was determined and analyzed under electron microscope before, 12 h, and 24 h after exposure to 20 mM BAPTA-AM. (h) Glial cell cultures (DIV 14) were exposed continuously to 20 mM or 100 mM BAPTA-AM. Cell death was analyzed 24 h later by measuring LDH release, mean^SEM (n 8 culture wells per condition). (Deckwerth et al. 1996) , oxygen-glucose deprivation (Gottron et al. 1997), or beta amyloid (Selznick et al. 2000) . Bax is translocated from the cytoplasm into mitochondria during apoptosis, which then activates release of cytochrome c and caspases (Deshmukh and Johnson 1998; Putcha et al. 1999) . To examine a potential role of Bax for BAPTA-AM-induced apoptosis, immunocytochemistry was performed to trace the subcellular redistribution of Bax. As reported (Putcha et al. 1999) , Bax-immunoreactive signal was observed primarily in cytoplasm in sham-operated control neurons (Fig. 4a) . Translocation to mitochondria, as apparent by a punctate staining pattern, was observed at 4±8 h following exposure to BAPTA-AM (Fig. 4b) . Western blot analysis showed decreased levels of Bax in cytosolic fraction, con®rming the translocation of Bax into mitochondria (Fig. 4c) .
Immunocytochemistry with cytochrome c revealed a punctate staining pattern in normal cortical neurons. This mitochondrial staining changed into a diffuse pattern 4±8 h following treatment with BAPTA-AM, suggesting that cytochrome c was released from mitochondria (Figs 5a and b). This was further supported by western blot analysis showing increased levels of cytochrome c in cytosolic fraction (Han and Gwag, unpublished data).
Additional experiment was performed to examine if BAPTA-AM induced activation of caspase-3, turning to a polyclonal antibody that recognizes the active fragment of caspase-3. Levels of the active caspase-3 were weakly observed in sham-operated cortical cell cultures. Treatment with 20 mm BAPTA-AM increased levels of the active caspase-3 within 4 h (Fig. 6a) . The active fragment of caspase-3 was observed by 12 h following BAPTA-AM when widespread neuronal apoptosis occurred. The microtubule-associated protein tau has been identi®ed as a substrate for caspase-3 (Ko et al. 2000) . We also found that treatment with BAPTA-AM for 4±20 h resulted in proteolytic cleavage of PHF-1 tau in cortical cell cultures (e) Sister cultures were exposed continuously to 20 mM BAPTA-AM, alone or with 100 mM zVAD, 100 mM DEVD, 100 mM trolox, or 10 mM MK-801 plus 50 mM CNQX (MK/CNQX). Neuronal death was analyzed 12 or 24 h later by counting viable neurons excluding trypan blue, mean^SEM (n 16±24 ®elds randomly chosen from four culture wells per condition). *Signi®cant difference from relevant control (BAPTA-AM alone at each time point), at p , 0.05 using analysis of variance and Student±Neuman±Keuls' test. (Fig. 6b) . BAPTA-AM-induced activation of caspase-3 was blocked by inclusion of 100 mm zVAD-fmk or 100 mm DEVD-amc, but not by 100 mm trolox (Fig. 6c) .
BAPTA-AM-induced necrosis: role of ROS
As BAPTA-AM-induced delayed necrosis was blocked by trolox, we analyzed if treatment with BAPTA-AM produced ROS in cortical neurons. Levels of¯uorescent DCF, the oxidation product of DCDHF-DA, were increased up to 3-fold in cortical neurons treated with 20 mm BAPTA-AM for 16 h (Fig. 7) . Levels of DCF remained increased over 20±24 h. We next analyzed levels of ROS in mitochondria by using dihydrorhodamine 123 that permeates mitochondrial membrane and then oxidized to the¯uorescent product rhodamine 123. The¯uorescent intensity of rhodamine 123 was increased within 8 h and lasted over 24 h in cortical neurons treated with 20 mm BAPTA-AM. Finally, we analyzed levels of superoxide by measuring¯uorescent intensity of ethidium that is produced by interaction of hydroethidine and superoxide. Compared with overall and mitochondrial ROS, levels of ethidium were increased as early as 4 h, lasted up to 12 h, and returned to the control value within 16 h in cortical neurons exposed to BAPTA-AM.
Additive neuroprotection of trolox and caspase inhibitors against BAPTA-AM-induced neuronal death Finally, we tested if increase in active casapse-3 and ROS would additively contribute to BAPTA-AM-induced neuronal death. Concurrent addition of zVAD-fmk or DEVD-amc with trolox prevented shrinkage and swelling of neuronal cell body 24 h following exposure to 20 mm BAPTA-AM (Figs 8a and b) . While either inhibitors of caspases or trolox showed little protection against neuronal injuries evolving 24 h after exposure to BAPTA-AM (Fig. 3e) , combined treatment with inhibitors of caspase and trolox showed near complete protection against BAPTA-AM-induced apoptosis and necrosis (Fig. 8c) .
Discussion
We report that the Ca 21 chelator BAPTA-AM produces rapidly evolving apoptosis (Ca 21 de®ciency-induced apoptosis, CDIA) and slowly evolving necrosis (Ca 21 de®ciency-induced necrosis, CDIN) in cultured cortical neurons. CDIA is featured by shrinkage of cell body and aggregation and condensation of nuclear chromatin and propagated through activation of Bax-cyctochrome c-caspase-3. CDIN is evident Cortical cell cultures (DIV 10±12) were exposed to 20 mM BAPTA-AM for indicated points of time and were subjected to Western blot analysis using (a) an antibody that recognizes the active fragment of caspase-3 or (b) PHF-1 antibody that recognizes a phosphorylated tau. (c) Sister cultures were exposed to a sham control (BL) or 20 mM BAPTA-AM (BAPTA) for 8 h, alone or with 100 mM zVAD (zVAD), 100 mM DEVD (DEVD), or 100 mM trolox (trolox).
Calcium de®ciency-induced apoptosis and necrosis 235 by marked cell body swelling and scattered nuclear chromatin and executed through the production of ROS.
When neurons are induced to die, they appear to follow either apoptosis or necrosis, depending upon the type and severity of the insult. For example, neurons deprived of neurotrophic factors or extracellular K 1 undergo degeneration exclusively through apoptosis (Martin et al. 1992; D'Mello et al. 1993) . Neurons exposed to staurosporine, a broad inhibitor of protein kinases, reveal hallmark of apoptosis . Morphological and biochemical studies demonstrate that excitotoxins such as NMDA, AMPA, or kainate solely produce necrosis regardless of doses . Administration of Fe
21
, a ROS-producing agent through Fenton chemistry, results in neuronal necrosis in cultured cells as well as in adult rat (Ryu et al. 1999; Won et al. 2000) . Ca 21 ionophores produce apoptosis at low doses and necrosis at high doses . In contrast, challenge with BAPTA-AM shows a unique pattern of neuronal death. At a single dose, it causes neuronal apoptosis in the early phase (within 12 h) and neuronal necrosis in the late phase (12±24 h).
Bax is a pro-apoptotic member of the Bcl-2 family, widely expressed in the nervous system, and appears to play a major role in the execution of neuronal apoptosis. During apoptosis, Bax is translocated into mitochondria in which it induces release of cytochrome c through mitochondrial permeability transition pore (Ju Èrgensmeier et al. 1998) . Although it remains to be delineated how Bax is activated to execute apoptosis, pH-sensitive conformational change of Bax appears to be required for the translocation into mitochondria (Khaled et al. 1999) . In addition, the present study raises the possibility that de®ciency in [Ca 21 ] i induces Bax translocation into mitochondria. Bax in the mitochondria then appears to activate release of cytochrome c and Reactive oxygen species were analyzed by measuring¯uorescent intensity from oxidation products of DCDHF-DA (total ROS, X), dihydrorhodamine 123 (mitochondrial ROS, P), and hydroethidine (superoxide, W), mean^SEM (n 30 neurons randomly chosen from three culture dishes for each condition). *Signi®cant difference from relevant control (t 0), at p , 0.05 using analysis of variance and Student± Neuman±Keuls' test.
caspase-3 as previously reported (Martinou et al. 1999; Putcha et al. 1999; Zou et al. 1999) .
Caspase-3 that is activated following deprivation of neurotrophic factors, calyculin A, staurosporine, or beta amyloid is required for execution of neuronal apoptosis (Milligan et al. 1995; Harada and Sugimoto 1999; Ko et al. 2000) . We found that treatment with BAPTA-AM activated caspase-3 and cleaved PHF-1 tau, a substrate of caspase-3, prior to CDIA. Inhibitors of caspases, zVAD-fmk or DEVDamc, prevented CDIA but did not reduce slowly evolving CDIN. Consistent with previous ®ndings that excitotoxicity or oxidative neuronal death occurs by necrosis Ryu et al. 1999) , neither glutamate antagonists nor antioxidants attenuated CDIA.
As the antioxidant trolox-blocked CDIN, we reasoned that ROS would be produced to mediate CDIN. Administration of BAPTA-AM resulted in rapid and transient production of superoxide that was accompanied by sequential production of mitochondrial ROS and intracellular total ROS. Analysis of intracellular calcium using¯uo3 demonstrated that treatment with BAPTA-AM caused rapid and transient decrease in [Ca 21 ] i . However, [Ca 21 ] i in cortical neurons was increased 8±16 h following exposure to BAPTA-AM (Kang and Gwag, unpublished data). The cytosolic Ca 21 can enter into mitochondria, which results in production of mitochondrial free radicals by interrupting the electron transport chain and collapsing the mitochondrial membrane potential (Dykens 1994; Dugan et al. 1995; Ward et al. 2000) . Accumulated ROS then triggered neuronal cell necrosis sensitive to cycloheximide that was shown to reduce ROS-mediated cytotoxicity by increasing levels of glutathione, a cofactor for the antioxidant glutathione peroxidase family (Ratan et al. 1994; Schulz et al. 1997) .
A single insult-driven apoptosis and necrosis appear to be interconverted. Neurons undergo excitotoxic necrosis following prolonged deprivation of oxygen and glucose. With blockade of excitotoxicity, neuronal apoptosis arises through activation of caspases Gottron et al. 1997) . We found that caspase inhibitors prevented CDIA but markedly increased CDIN. Blockade of CDIN by trolox enhanced CDIA. This suggests that CDIA and CDIN compete for routes to death. Thus, blocking one route renders neurons highly vulnerable to the other. In line with this, caspase inhibitors and trolox synergistically prevented BAPTA-AM neurotoxicity by blocking CDIA and CDIN, respectively. The combined neuroprotection of antiapoptosis agents (e.g. caspase inhibitors or cycloheximide) and antinecrosis agents (e.g. glutamate antagonists) was shown in reducing neuronal death following hypoxic ischemia that produces apoptosis and necrosis (Ma et al. 1998) .
Excess accumulation of [Ca 21 ] i has been implicated in the pathogenesis of hypoxic ischemia, trauma, and axotomy (Tecoma et al. 1989; Choi and Rothman 1990; George et al. 1995) . Basal levels and in¯ux of [Ca 21 ] i in neurons and lymphocytes were signi®cantly reduced in aging and Alzheimer's disease (Grossmann et al. 1993; Hartmann et al. 1996) , suggesting that de®ciency in [Ca 21 ] i contribute to neuronal death. While selective accumulation of [Ca 21 ] i causes neuronal apoptosis Yu et al. 1999) , de®ciency in [Ca 21 ] i produces caspasemediated apoptosis and ROS-mediated necrosis.
